Janssen Search
Search results
Fighting Multi-Drug Resistant Tuberculosis
Fighting Multi-Drug Resistant Tuberculosis (MDR-TB) Creating Long-Term, Sustainable Solutions More than 480,000 new cases of multi-drug resistant tuberculosis (MDR-TB) were reported worldwide in 2013, and only 20 percent of MDR-TB patients were enrolled ...
The Crossroads of Diabetes and Kidney Health
The Crossroads of Diabetes and Kidney Health The kidneys play an important role in maintaining our overall health. While these bean-shaped organs perform multiple functions, a primary role is filtration, critical to clearing waste such as urea and to ...
First 1000 Days QuickFire Challenge
First 1000 Days QuickFire Challenge A first heartbeat. First smile. First step. The First 1000 Days of life are the most critical in human development. This unique window immensely impacts the trajectory of health. As the overall approach to healthcare ...
Aiming to Change the Trajectory of Human Health – Starting from Birth
Aiming to Change the Trajectory of Human Health – Starting from Birth While childhood allergic disease is often diagnosed a few years after birth, recent science indicates that some root causes of disease may initiate early in life. 1 Pregnancy and ...
Oncology Disease Area Strongholds
Disease Area Strongholds We are aligned from laboratory bench through post-approval research. Focused Solutions To execute our overarching strategy, we have created internal Disease Area Strongholds (DAS) whose function is to: Focus on particular tumor ...
Partners in Cardiovascular & Metabolism
Partner with Janssen in Cardiovascular & Metabolism Our one team philosophy guides us and our partners toward a shared vision: eliminating cardiovascular and metabolic diseases so all people can lead happier, healthier, longer lives. Seeking the Best ...
WCLC Newsroom
Thank you for visiting the Janssen Oncology newsroom to learn more about our research that will be presented at the International Association for the Study of Lung Cancer’s (IASLC) virtual 2020 World Conference on Lung Cancer Singapore (WCLC). Janssen ...
Gabriele Ronnett, M.D., Ph.D.
As the Gestational Diabetes Mellitus (GDM) Venture Leader of the Disease Interception Accelerator (DIA), Gabriele Ronnett is responsible for driving GDM interception efforts within the DIA. She and her team work closely with the Type 2 Diabetes Disease ...
Katie Abouzahr, M.D.
KATIE ABOUZAHR, M.D. VICE PRESIDENT AUTOANTIBODY PORTFOLIO AND MATERNAL FETAL DISEASE AREA LEADER Katie Abouzahr, M.D., is Vice President, Autoantibody (AAb) Portfolio and Maternal Fetal Disease Area Leader at Janssen Research and Development (R&D), ...
Immunosciences
Immunosciences The Immunosciences group is focused on advancing two core areas of research: adaptive immunity and innate immunity. The adaptive immunity team is investigating mechanisms of antigen recognition and the subsequent initiation of T and B-cell ...